即時搜尋
中華 A80 指數 :
中華香港內地指數 :
中國 120 指數 :
大市總成交 :

Elliott Statement on Alexion

2019-12-10 09:50:00

LONDON -- (BUSINESS WIRE) -- Funds advised by Elliott Advisors (UK) Limited (together “Elliott” or “we”) acknowledge the statement issued by Alexion Pharmaceuticals, Inc. (“Alexion” or “the Company”) on Friday.

Elliott confirms that it has had a multiyear, constructive and private engagement with Alexion that has led to value-creative changes at the Company. Despite two years of strong execution that bolstered the Company’s strategic value, we believe Alexion remains significantly undervalued by the market. Elliott is encouraged by the Board’s public commitment to evaluate any inbound interest and its overall commitment to shareholder value creation. Elliott remains of the view that Alexion would be a highly valuable strategic and financial asset for a number of larger pharmaceutical companies. We also continue to believe that a proactive approach would maximise the chance of an optimal outcome.

We look forward to continuing our dialogue with the Company in an effort to close the gap between its current share price and its fundamental value.

About Elliott

Elliott Management Corporation manages two multi-strategy investment funds which combined have approximately $38.2 billion of assets under management. Its flagship fund, Elliott Associates, L.P., was founded in 1977, making it one of the oldest funds under continuous management. The Elliott funds’ investors include pension plans, sovereign wealth funds, endowments, foundations, funds-of-funds, high net worth individuals and families, and employees of the firm. Elliott Advisors (UK) Limited is an affiliate of Elliott Management Corporation.

View source version on businesswire.com: https://www.businesswire.com/news/home/20191209005485/en/

CONTACT:

Media Contacts
Sarah Rajani CFA
Elliott Advisors (UK) Limited
+44 (0) 20 3009 1475
srajani@elliottadvisors.co.uk

原文連結

美國商業資訊

2020-08-11
19:08:00
富瑞宣佈與菲律賓的Regis Partners建立聯合品牌合作關係
19:04:00
Blackrock Microsystems獲得Wyss中心即時神經訊號處理平臺的授權
19:02:00
FINEOS收購Limelight Health
16:29:00
挪威利用Everbridge公共預警提醒在國外旅行的公民降低COVID-19風險
13:54:00
Amazon Project Zero Launches in Seven New Countries
10:18:00
CyberArk被評為2020年Gartner特權存取管理魔力象限的領導者
10:11:00
五款麒麟專利Plasma乳酸菌產品註冊為「機能性表示食品」
09:43:00
國泰君安國際公佈2020中期業績
2020-08-10
13:24:00
Novavax和武田宣佈在日本合作Novavax的COVID-19候選疫苗
2020-08-07
18:37:00
Wipro與英特爾合作推動業務連續性
17:11:00
Rimini Street公佈2020年第二季財務業績
14:56:00
Andersen Global與布吉納法索的CFA Afrique達成合作協定
14:52:00
Eyenuk宣布FDA核准EyeArt自主AI系統用於糖尿病視網膜病變篩查
14:49:00
全球投資人法律顧問ROSEN鼓勵英特爾公司投資人在尋求彌補投資人損失的INTC集體訴訟重要截止日期前與事務所連絡
13:59:00
SolarWinds榮獲兩項創新類亞太Stevie獎
13:53:00
Diligent Corporation獲得Clearlake Capital和黑石的新投資
11:30:00
Rimini Street透過縮短保證回應時間進一步加快軟體問題的解決速度
09:45:00
中美冠科任命新的營運長,預示公司將增加對數位轉型的投資
09:41:00
株式會社Lead Real Estate與GRIP、Securitize、Rialto合作,透過優先股的數字證券化進行募資
09:39:00
Eaton InfiniTrac™ Electronic Limited Slip Differential Delivers Optimized Performance, Scalable Application and Seamless Response
回頁頂